Skip to content

This extraction-less kit is a rapid, non-isothermal nucleic acid amplification qSTAR method intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory swabs collected from individuals suspected of COVID-19 by their healthcare provider (HCP).

This test is also authorized for use with swab specimens collected from any individual, including individuals without symptoms or other reasons to suspect COVID-19.

  • Reliable and robust performance when compared to traditional RT-PCR tests
  • Increased throughput with 5:1 pooling on 96-well RT-PCR instruments
  • Direct amplification in under 20 minutes drives lab's efficiency and productivity
  • EUA-FDA validated
  • Automation compatible
  • Accurate detection with reduced complexity and fast turn-around times
  • Excellent sensitivity with CDC-recommended primers and qPCR instruments
  • Stringently developed and tested to optimize reproducibility and consistency
  • All enzymes are synthesized in the United States

Compare products

{"one"=>"Select 2 or 3 items to compare", "other"=>"{{ count }} of 3 items selected"}

Select first item to compare

Select second item to compare

Select third item to compare